TSPO and Alzheimer disease: In addition to evidence from cellular and animal models, translocator protein (TSPO) PET studies have demonstrated microglial activation in humans with AD [148, 149], including reports that microglial activation inversely correlates with hippocampal volume and metabolism [148, 150], while correlating positively with amyloid load [148].